Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qi,Chen

第一单位： Peking University People's Hospital, Beijing, China.;Peking University Institute of Hematology, Beijing, China.;National Clinical Research Center for Hematologic Disease, Beijing, China.;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.

作者： Qi,Chen ^[1] ; Xin,Zhao ^[1] ; Hai-Xia,Fu ^[1] ; Yu-Hong,Chen ^[1] ; Yuan-Yuan,Zhang ^[1] ; Jing-Zhi,Wang ^[1] ; Yu,Wang ^[1] ; Feng-Rong,Wang ^[1] ; Xiao-Dong,Mo ^[1] ; Wei,Han ^[1] ; Huan,Chen ^[1] ; Ying-Jun,Chang ^[1] ; Lan-Ping,Xu ^[1] ; Kai-Yan,Liu ^[1] ; Xiao-Jun,Huang ^[1] ; Xiao-Hui,Zhang ^[2]

作者单位： Peking University People's Hospital, Beijing, China.;Peking University Institute of Hematology, Beijing, China.;National Clinical Research Center for Hematologic Disease, Beijing, China.;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. ^[1] Peking University People's Hospital, Beijing, China. zhangxh100@sina.com.;Peking University Institute of Hematology, Beijing, China. zhangxh100@sina.com.;National Clinical Research Center for Hematologic Disease, Beijing, China. zhangxh100@sina.com.;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. zhangxh100@sina.com. ^[2]